Примери за използване на Secondary hyperparathyroidism на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Secondary Hyperparathyroidism.
If you are being treated for secondary hyperparathyroidism.
Secondary Hyperparathyroidism.
If they fail to do so, the result will be anemia, secondary hyperparathyroidism and osteoporosis.
Secondary hyperparathyroidism, not elsewhere classified.
X-ray examination helps to detect the signs of bone damage in secondary hyperparathyroidism.
To treat secondary hyperparathyroidism.
X-ray examination helps to detect the signs of bone damage in secondary hyperparathyroidism.
Primary and secondary hyperparathyroidism: symptoms and treatment.
Parareg is used in adults andelderly patients:• to treat secondary hyperparathyroidism.
To treat secondary hyperparathyroidism in patients with kidney disease on dialysis.
Ultrasound examination of the parathyroid glands in patients with secondary hyperparathyroidism- 44, 2008, No 1, 62-67.
In primary and secondary hyperparathyroidism too much PTH is produced by the parathyroids.
Tertiary hyperparathyroidism occurs when hypercalcemia occurs during the course of secondary hyperparathyroidism.
If you are being treated for secondary hyperparathyroidism, your doctor should monitor your calcium.
Tertiary hyperparathyroidism occurs when hypercalcemia occurs during the course of secondary hyperparathyroidism.
The secondary hyperparathyroidism is characterized by the symptoms of chronic renal failure.
The aim of this study was to established the allele distributions of VDR Fok I polymorphism andits influence on development of secondary hyperparathyroidism in predialysis stage.
In secondary hyperparathyroidism, the recommended starting dose for adults is 30 mg once a day.
Key words: chronic renal failure, secondary hyperparathyroidism, parathyroid hormone, ultrasound examination of parathyroid glands.
Secondary hyperparathyroidism occurs when, due to a disease, there is a decrease in serum calcium.
The most common side effects with Mimpara in secondary hyperparathyroidism(seen in more than 1 patient in 10) are nausea(feeling sick) and vomiting.
Secondary hyperparathyroidism is the situation where disease outside of the parathyroid gland leads to excessive secretion of parathyroid hormone.
Parsabiv is indicated for the treatment of secondary hyperparathyroidism(SHPT) in adult patients with chronic kidney disease(CKD) on haemodialysis therapy.
Secondary hyperparathyroidism can cause the loss of calcium from the bones, which can lead to bone pain and fractures and problems with blood and heart vessels.
Treatment of secondary hyperparathyroidism(HPT) in patients with end-stage renal disease(ESRD) on maintenance dialysis therapy.
Secondary hyperparathyroidism maintains serum calcium in the normal range at the expense of mobilizing calcium from the skeleton and increasing phosphorus wasting in the kidneys.
Treatment of secondary hyperparathyroidism(HPT) in patients with end-stage renal disease(ESRD) on maintenance dialysis therapy.
Secondary hyperparathyroidism is encountered most commonly in patients with chronic renal failure but may occur in association with vitamin D deficiency, renal tubular acidosis or intestinal malabsorption.
If you are being treated for secondary hyperparathyroidism, your doctor should monitor your calcium levels before starting treatment with Mimpara and during treatment with Mimpara.